Vext Science, Inc.
VEXTF
$0.20
$0.014.32%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.42% | 8.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.42% | 8.35% | |||
| Cost of Revenue | -36.15% | 19.47% | |||
| Gross Profit | 65.71% | -16.02% | |||
| SG&A Expenses | -38.85% | 120.97% | |||
| Depreciation & Amortization | 364.73% | -122.27% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.69% | 17.32% | |||
| Operating Income | 100.00% | -94.82% | |||
| Income Before Tax | 92.90% | -215.33% | |||
| Income Tax Expenses | -83.44% | 718.93% | |||
| Earnings from Continuing Operations | 91.55% | -301.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 91.55% | -301.71% | |||
| EBIT | 100.00% | -94.82% | |||
| EBITDA | 316.31% | -61.52% | |||
| EPS Basic | 91.55% | -301.89% | |||
| Normalized Basic EPS | 77.59% | -127.45% | |||
| EPS Diluted | 91.57% | -302.83% | |||
| Normalized Diluted EPS | 77.59% | -127.45% | |||
| Average Basic Shares Outstanding | 0.00% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||